Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against Type 2 diabetes in Japanese

Pharmacogenomics

Volumn 8, Issue 10, 2007, Pages 1307-1314

  Hori, Masaharu ^a   Oniki, Kentaro ^a   Ueda, Kentaro ^a   Goto, Shuji ^a   Mihara, Shuichi ^b   Marubayashi, Toru ^b   Nakagawa, Kazuko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Japanese Red Cross Society   (Japan)

Author keywords

Genetic polymorphism; Glutathione S transferase; Smoking; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; DNA; GLUCOSE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE;

ADULT; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED;

EID: 36448996114     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.10.1307     Document Type: Article

References (34)

1. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801 (2006).
2. Evans JL. Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of Type 2 diabetes. Endocr. Rev. 23, 599-622 (2002).
3. Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance. diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24, 816-823 (2004).
4. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE: Elevated risk of cardiovascular disease prior to clinical diagnosis of Type 2 diabetes. Diabetes Care 25, 1129-1134 (2002).
5. Booth GL, Kapral MK, Fung K, Tu JV: Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29, 32-37 (2006).
6. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M: Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368, 1651-1659 (2006).
7. Stern MP: Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44, 369-374 (1995).
8. Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88 (2005).
9. Hayes JD, Strange RC: Glutathione S-transferase polymorphisms and their biological consequences. Pharmacolgy 61, 154-166 (2000).
10. Cotton SC, Sharp L, Little J, Brockton N: Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 151, 7-32 (2000).
11. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA Jr: Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res. 50, 1585-1590 (1990).
12. Foy CG, Bell RA, Farmer DF, Goff DC Jr, Wagenknecht LE: Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care 28. 2501-2507 (2005).
13. Eliasson B: Cigarette smoking and diabetes. Prog. Cardiovasc. Dis. 45, 405-413 (2003).
14. Doney AS, Lee S, Leese GP, Morris AD, Palmer CN: Increased cardiovascular morbidity and mortality in Type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 111, 2927-2934(2005).
15. Hayek T, Stephens JW, Hubbart CS et al.: A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 184, 404-412 (2006).
16. Wang G, Zhang L, Li Q: Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem. Biophys. Res. Commun. 341, 310-313 (2006).
17. Yalin S, Hatungil R, Tamer L et al.: Glutathione S-transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem. Funct. 25(5), 509-513 (2007)
18. Fujita H, Narita T, Meguro, H et al.: No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese Type 2 diabetic patients. Ren. Fail. 22, 479-486 (2000).
19. Yang Y, Kao MT, Chang CC et al.: Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int. J. Mol. Med. 14, 855-859 (2004).
20. Bekris LM, Shephard C, Peterson M et al.: Glutathione-S-transferase M1 and T1 polymorphisms and associations with Type 1 diabetes age-at-onset. Autoimmunity 38, 567-575 (2005).
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197 (1997).
22. Ueda K, Ishitsu T, Seo T et al.: Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity. Pharmacogenomics 8, 435-442 (2007).
23. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N: T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med Genet. 7, 38 (2006).
24. Tamer L, Ercan B, Camsari A et al.: Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic. Res. Cardiol. 99,223-229 (2004).
25. Masetti S, Botto N, Manfredi S et al.: Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J. Mol. Med. 81, 488-494, (2003).
26. Miller EA, Pankow JS, Millikan RC et al.: Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis. and endothelial function: the Atherosclerosis Risk In Communities (ARIC) study. Atherosclerosis 171, 265-272 (2003).
27. Townsend DM, Tew KD, Tapiero H: The importance of glutathione in human disease. Biomed. Pharmacother. 57, 145-155 (2003).
28. Morita H, Ikeda H, Haramaki N. Eguchi H, Imaizumi T: Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J. Am. Coll. Cardiol. 45, 589-594 (2005).
29. Eliasson B, Attvall S, Taskinen MR, Smith U: Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur. J. Clin. Invest. 27. 450-456 (1997).
30. Pemble S, Schroeder KR, Spencer SR et al.: Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300 (Pt 1), 271-276 (1994).
31. Wang L, Groves MJ, Hepburn MD, Bowen DT: Glutathione S-transferase enzyme expression in hematopoietic cell lines irnplieia differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages. Haematologia, 85, 573-579 (2000).
32. Tsantes AE, Bonovas S, Travlou A, Sitaras NM: Redox imbalance, macrocytosis, and RBC homeostasis. Antioxid Redox Signal. 8, 1205-1216 (2006).
33. Straface E, Rivabene R, Masella R. Santulli M, Paganelli R, Malorni W: Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine. Biochem. Biophys. Res. Commun. 290, 1393-1398 (2002).
34. Sailaja YR, Baskar R, Saralakumari D: The antioxidant status during maturation of reticulocytes to erythrocytes in Type 2 diabetics. Free Radic. Biol. Med. 35, 133-139 (2003).